MCC
AMPH icon

Money Concepts Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Money Concepts Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-602
Closed -$16.9K – 560
2022
Q4 		$16.9K Sell
602
-9,497
-94% -$276K ﹤0.01% 1759
2022
Q3 		$284K Buy
10,099
+454
+5% +$14.8K 0.02% 373
2022
Q2 		$341K Buy
9,645
+543
+6% +$19.4K 0.03% 331
2022
Q1 		$327K Sell
9,102
-528
-5% -$15K 0.02% 559
2021
Q4 		$224K Buy
+9,630
New +$197K 0.02% 461

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Money Concepts Capital's AMPH Position: Q1 2023 in Review

Money Concepts Capital sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2023, closing a stake of 602 shares — an estimated $16.9K sold.

Money Concepts Capital first reported a position in AMPH in Q4 2021 and held it in 5 quarters. The position peaked at $341K in Q2 2022. 218 funds tracked by Wall St. Rank hold AMPH as of Q1 2023.

  • Money Concepts Capital reported no remaining Amphastar Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • Money Concepts Capital sold 602 Amphastar Pharmaceuticals shares in Q1 2023, an estimated $16.9K.
  • Money Concepts Capital first reported a position in Amphastar Pharmaceuticals in Q4 2021 and held it in 5 quarters.
  • Money Concepts Capital's Amphastar Pharmaceuticals position peaked at $341K in Q2 2022.
  • 218 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.